{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:35:38Z","timestamp":1793136938083,"version":"4.5.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,6,9]],"date-time":"2012-06-09T00:00:00Z","timestamp":1339200000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00198-012-2030-x","type":"journal-article","created":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T21:27:02Z","timestamp":1339190822000},"page":"2735-2748","source":"Crossref","is-referenced-by-count":228,"title":["Osteoporosis in young adults: pathophysiology, diagnosis, and management"],"prefix":"10.1007","volume":"23","author":[{"name":"For the IOF Committee of Scientific Advisors Working Group on Osteoporosis Pathophysiology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Eisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Foldes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Stepan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-C.","family":"de Vernejoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,9]]},"reference":[{"key":"2030_CR1","unstructured":"(1991) Diagnosis, prophylaxis and treatment of osteoporosis. In American Journal of Medicine. Consensus development conference, 90, pp 170\u2013210"},{"key":"2030_CR2","unstructured":"(1994) World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series. In. Geneva"},{"key":"2030_CR3","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00198-006-0160-8","volume":"17","author":"E Seeman","year":"2006","unstructured":"Seeman E, Bianchi G, Khosla S, Kanis JA, Orwoll E (2006) Bone fragility in men\u2014where are we? Osteoporos Int 17:1577\u20131583","journal-title":"Osteoporos Int"},{"key":"2030_CR4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","volume":"18","author":"JA Kanis","year":"2007","unstructured":"Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033\u20131046","journal-title":"Osteoporos Int"},{"key":"2030_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.maturitas.2008.11.022","volume":"62","author":"J Compston","year":"2009","unstructured":"Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P, Wilkins M (2009) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50\u00a0years in the UK. Maturitas 62:105\u2013108","journal-title":"Maturitas"},{"key":"2030_CR6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00198-008-0559-5","volume":"19","author":"B Dawson-Hughes","year":"2008","unstructured":"Dawson-Hughes B, Tosteson AN, Melton LJ 3rd, Baim S, Favus MJ, Khosla S, Lindsay RL (2008) Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int 19:449\u2013458","journal-title":"Osteoporos Int"},{"key":"2030_CR7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399\u2013428","journal-title":"Osteoporos Int"},{"key":"2030_CR8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bone.2007.07.008","volume":"41","author":"ML Bianchi","year":"2007","unstructured":"Bianchi ML (2007) Osteoporosis in children and adolescents. Bone 41:486\u2013495","journal-title":"Bone"},{"key":"2030_CR9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jocd.2007.12.007","volume":"11","author":"S Baim","year":"2008","unstructured":"Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Lewiecki EM, Silverman S (2008) Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom 11:75\u201391","journal-title":"J Clin Densitom"},{"key":"2030_CR10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000103005","volume":"51","author":"JP Bonjour","year":"2007","unstructured":"Bonjour JP, Chevalley T, Rizzoli R, Ferrari S (2007) Gene\u2013environment interactions in the skeletal response to nutrition and exercise during growth. Med Sport Sci 51:64\u201380","journal-title":"Med Sport Sci"},{"key":"2030_CR11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1210\/jc.2004-1043","volume":"90","author":"T Chevalley","year":"2005","unstructured":"Chevalley T, Rizzoli R, Hans D, Ferrari S, Bonjour JP (2005) Interaction between calcium intake and menarcheal age on bone mass gain: an eight-year follow-up study from prepuberty to postmenarche. J Clin Endocrinol Metab 90:44\u201351","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/jc.83.2.358","volume":"83","author":"S Ferrari","year":"1998","unstructured":"Ferrari S, Rizzoli R, Slosman D, Bonjour JP (1998) Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab 83:358\u2013361","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR13","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2106\/00004623-198971080-00016","volume":"71","author":"DA Bailey","year":"1989","unstructured":"Bailey DA, Wedge JH, McCulloch RG, Martin AD, Bernhardson SC (1989) Epidemiology of fractures of the distal end of the radius in children as associated with growth. J Bone Joint Surg Am 71:1225\u20131231","journal-title":"J Bone Joint Surg Am"},{"key":"2030_CR14","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1359\/jbmr.060601","volume":"21","author":"EM Clark","year":"2006","unstructured":"Clark EM, Ness AR, Bishop NJ, Tobias JH (2006) Association between bone mass and fractures in children: a prospective cohort study. J Bone Miner Res 21:1489\u20131495","journal-title":"J Bone Miner Res"},{"key":"2030_CR15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1359\/jbmr.051215","volume":"21","author":"SL Ferrari","year":"2006","unstructured":"Ferrari SL, Chevalley T, Bonjour JP, Rizzoli R (2006) Childhood fractures are associated with decreased bone mass gain during puberty: an early marker of persistent bone fragility? J Bone Miner Res 21:501\u2013507","journal-title":"J Bone Miner Res"},{"key":"2030_CR16","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.290.11.1479","volume":"290","author":"S Khosla","year":"2003","unstructured":"Khosla S, Melton LJ 3rd, Dekutoski MB, Achenbach SJ, Oberg AL, Riggs BL (2003) Incidence of childhood distal forearm fractures over 30\u00a0years: a population-based study. JAMA 290:1479\u20131485","journal-title":"JAMA"},{"key":"2030_CR17","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1210\/jc.2010-2546","volume":"96","author":"AM Boyce","year":"2011","unstructured":"Boyce AM, Gafni RI (2011) Approach to the child with fractures. J Clin Endocrinol Metab 96:1943\u20131952","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1138\/20060240","volume":"3","author":"S Ferrari","year":"2006","unstructured":"Ferrari S (2006) Single gene mutations and variations affecting bone turnover and strength. BoneKey 3:11\u201329","journal-title":"BoneKey"},{"key":"2030_CR19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bone.2009.10.005","volume":"46","author":"R Rizzoli","year":"2010","unstructured":"Rizzoli R, Bianchi ML, Garabedian M, McKay HA, Moreno LA (2010) Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly. Bone 46:294\u2013305","journal-title":"Bone"},{"key":"2030_CR20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1359\/jbmr.060108","volume":"21","author":"F Rauch","year":"2006","unstructured":"Rauch F, Travers R, Glorieux FH (2006) Cellular activity on the seven surfaces of iliac bone: a histomorphometric study in children and adolescents. J Bone Miner Res 21:513\u2013519","journal-title":"J Bone Miner Res"},{"key":"2030_CR21","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(02)08706-8","volume":"359","author":"E Seeman","year":"2002","unstructured":"Seeman E (2002) Pathogenesis of bone fragility in women and men. Lancet 359:1841\u20131850","journal-title":"Lancet"},{"key":"2030_CR22","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1210\/jc.2006-2613","volume":"92","author":"P Nordstrom","year":"2007","unstructured":"Nordstrom P, Neovius M, Nordstrom A (2007) Early and rapid bone mineral density loss of the proximal femur in men. J Clin Endocrinol Metab 92:1902\u20131908","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1359\/jbmr.071020","volume":"23","author":"BL Riggs","year":"2008","unstructured":"Riggs BL, Melton LJ, Robb RA, Camp JJ, Atkinson EJ, McDaniel L, Amin S, Rouleau PA, Khosla S (2008) A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res 23:205\u2013214","journal-title":"J Bone Miner Res"},{"key":"2030_CR24","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1172\/JCI112462","volume":"77","author":"BL Riggs","year":"1986","unstructured":"Riggs BL, Wahner HW, Melton LJ 3rd, Richelson LS, Judd HL, Offord KP (1986) Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest 77:1487\u20131491","journal-title":"J Clin Invest"},{"key":"2030_CR25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.beem.2008.08.007","volume":"22","author":"S Ferrari","year":"2008","unstructured":"Ferrari S (2008) Human genetics of osteoporosis. Best Pract Res Clin Endocrinol Metab 22:723\u2013735","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2030_CR26","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1469-1809.2008.00447.x","volume":"72","author":"D Karasik","year":"2008","unstructured":"Karasik D, Ferrari SL (2008) Contribution of gender-specific genetic factors to osteoporosis risk. Ann Hum Genet 72:696\u2013714","journal-title":"Ann Hum Genet"},{"key":"2030_CR27","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/01.MIB.0000188341.96726.15","volume":"11","author":"FA Sylvester","year":"2005","unstructured":"Sylvester FA (2005) IBD and skeletal health: children are not small adults! Inflamm Bowel Dis 11:1020\u20131023","journal-title":"Inflamm Bowel Dis"},{"key":"2030_CR28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bone.2010.10.173","volume":"48","author":"R Haidar","year":"2011","unstructured":"Haidar R, Musallam KM, Taher AT (2011) Bone disease and skeletal complications in patients with beta thalassemia major. Bone 48:425\u2013432","journal-title":"Bone"},{"key":"2030_CR29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.contraception.2005.02.003","volume":"71","author":"AM Kaunitz","year":"2005","unstructured":"Kaunitz AM, Shields WC (2005) Contraceptive equity and access in the United States: a 2005 update. Contraception 71:317\u2013318","journal-title":"Contraception"},{"key":"2030_CR30","doi-asserted-by":"crossref","unstructured":"Lopez LM, Grimes DA, Schulz KF, Curtis KM (2011) Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev CD006033","DOI":"10.1002\/14651858.CD006033.pub4"},{"key":"2030_CR31","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00198-008-0689-9","volume":"19","author":"EM Lewiecki","year":"2008","unstructured":"Lewiecki EM, Gordon CM, Baim S et al (2008) Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry. Osteoporos Int 19:1369\u20131378","journal-title":"Osteoporos Int"},{"key":"2030_CR32","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00198-010-1293-3","volume":"22","author":"PL Jager","year":"2011","unstructured":"Jager PL, Jonkman S, Koolhaas W, Stiekema A, Wolffenbuttel BH, Slart RH (2011) Combined vertebral fracture assessment and bone mineral density measurement: a new standard in the diagnosis of osteoporosis in academic populations. Osteoporos Int 22:1059\u20131068","journal-title":"Osteoporos Int"},{"key":"2030_CR33","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01623782","volume":"7","author":"JA Kanis","year":"1997","unstructured":"Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D (1997) Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int 7:390\u2013406","journal-title":"Osteoporos Int"},{"key":"2030_CR34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00774-007-0799-z","volume":"26","author":"JM Liu","year":"2008","unstructured":"Liu JM, Zhao HY, Ning G, Chen Y, Zhang LZ, Sun LH, Zhao YJ, Xu MY, Chen JL (2008) IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women. J Bone Miner Metab 26:159\u2013164","journal-title":"J Bone Miner Metab"},{"key":"2030_CR35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0025-7753(01)71732-0","volume":"116","author":"M Diaz Curiel","year":"2001","unstructured":"Diaz Curiel M, Garcia JJ, Carrasco JL, Honorato J, Perez Cano R, Rapado A, Alvarez Sanz C (2001) Prevalence of osteoporosis assessed by densitometry in the Spanish female population. Med Clin (Barc) 116:86\u201388","journal-title":"Med Clin (Barc)"},{"key":"2030_CR36","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","volume":"133","author":"CN Bernstein","year":"2000","unstructured":"Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN (2000) The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med 133:795\u2013799","journal-title":"Ann Intern Med"},{"key":"2030_CR37","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/MEG.0b013e3282f8888b","volume":"20","author":"AC Heijckmann","year":"2008","unstructured":"Heijckmann AC, Huijberts MS, Schoon EJ et al (2008) High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 20:740\u2013747","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl 4","key":"2030_CR38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2036.2004.02057.x","volume":"20","author":"CM Schulte","year":"2004","unstructured":"Schulte CM (2004) Review article: bone disease in inflammatory bowel disease. Aliment Pharmacol Ther 20(Suppl 4):43\u201349","journal-title":"Aliment Pharmacol Ther"},{"key":"2030_CR39","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/gut.52.4.518","volume":"52","author":"K Thomason","year":"2003","unstructured":"Thomason K, West J, Logan RF, Coupland C, Holmes GK (2003) Fracture experience of patients with coeliac disease: a population based survey. Gut 52:518\u2013522","journal-title":"Gut"},{"key":"2030_CR40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.amjmed.2009.01.022","volume":"122","author":"T Ali","year":"2009","unstructured":"Ali T, Lam D, Bronze MS, Humphrey MB (2009) Osteoporosis in inflammatory bowel disease. Am J Med 122:599\u2013604","journal-title":"Am J Med"},{"key":"2030_CR41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/eat.10101","volume":"32","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Emborg C, Stoving RK, Hagen C, Mosekilde L, Brixen K (2002) Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders\u2014a nationwide register study. Int J Eat Disord 32:301\u2013308","journal-title":"Int J Eat Disord"},{"key":"2030_CR42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s001980170104","volume":"12","author":"SL Elkin","year":"2001","unstructured":"Elkin SL, Fairney A, Burnett S, Kemp M, Kyd P, Burgess J, Compston JE, Hodson ME (2001) Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int 12:366\u2013372","journal-title":"Osteoporos Int"},{"key":"2030_CR43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00223-006-0117-0","volume":"80","author":"M Rossini","year":"2007","unstructured":"Rossini M, Viapiana O, Del Marco A, de Terlizzi F, Gatti D, Adami S (2007) Quantitative ultrasound in adults with cystic fibrosis: correlation with bone mineral density and risk of vertebral fractures. Calcif Tissue Int 80:44\u201349","journal-title":"Calcif Tissue Int"},{"key":"2030_CR44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.prrv.2009.05.001","volume":"10","author":"I Sermet-Gaudelus","year":"2009","unstructured":"Sermet-Gaudelus I, Castanet M, Retsch-Bogart G, Aris RM (2009) Update on cystic fibrosis-related bone disease: a special focus on children. Paediatr Respir Rev 10:134\u2013142","journal-title":"Paediatr Respir Rev"},{"key":"2030_CR45","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00198-005-0013-x","volume":"17","author":"LA Ahmed","year":"2006","unstructured":"Ahmed LA, Joakimsen RM, Berntsen GK, Fonnebo V, Schirmer H (2006) Diabetes mellitus and the risk of non-vertebral fractures: the Tromso study. Osteoporos Int 17:495\u2013500","journal-title":"Osteoporos Int"},{"key":"2030_CR46","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.2337\/diacare.28.12.2850","volume":"28","author":"J Miao","year":"2005","unstructured":"Miao J, Brismar K, Nyren O, Ugarph-Morawski A, Ye W (2005) Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden. Diabetes Care 28:2850\u20132855","journal-title":"Diabetes Care"},{"key":"2030_CR47","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","volume":"48","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2005) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48:1292\u20131299","journal-title":"Diabetologia"},{"key":"2030_CR48","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/ard.2005.048835","volume":"65","author":"JM Burnham","year":"2006","unstructured":"Burnham JM, Shults J, Weinstein R, Lewis JD, Leonard MB (2006) Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database. Ann Rheum Dis 65:1074\u20131079","journal-title":"Ann Rheum Dis"},{"key":"2030_CR49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jbspin.2004.07.011","volume":"72","author":"I Legroux-Gerot","year":"2005","unstructured":"Legroux-Gerot I, Vignau J, Collier F, Cortet B (2005) Bone loss associated with anorexia nervosa. Joint Bone Spine 72:489\u2013495","journal-title":"Joint Bone Spine"},{"key":"2030_CR50","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0025-6196(11)63994-3","volume":"74","author":"AR Lucas","year":"1999","unstructured":"Lucas AR, Melton LJ 3rd, Crowson CS, O'Fallon WM (1999) Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc 74:972\u2013977","journal-title":"Mayo Clin Proc"},{"key":"2030_CR51","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1099-0968(200003)8:2<108::AID-ERV341>3.0.CO;2-0","volume":"8","author":"S Zipfel","year":"2000","unstructured":"Zipfel S, Herzog W, Beumont PJ, Russell J (2000) Osteoporosis. Eur Eat Disord Rev 8:108\u2013116","journal-title":"Eur Eat Disord Rev"},{"key":"2030_CR52","doi-asserted-by":"crossref","first-page":"E132","DOI":"10.1152\/ajpendo.00241.2006","volume":"292","author":"C Bossu","year":"2007","unstructured":"Bossu C, Galusca B, Normand S, Germain N, Collet P, Frere D, Lang F, Laville M, Estour B (2007) Energy expenditure adjusted for body composition differentiates constitutional thinness from both normal subjects and anorexia nervosa. Am J Physiol Endocrinol Metab 292:E132\u2013E137","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2030_CR53","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1017\/S0007114509274733","volume":"102","author":"D Fernandez-Garcia","year":"2009","unstructured":"Fernandez-Garcia D, Rodriguez M, Garcia Aleman J, Garcia-Almeida JM, Picon MJ, Fernandez-Aranda F, Tinahones FJ (2009) Thin healthy women have a similar low bone mass to women with anorexia nervosa. Br J Nutr 102:709\u2013714","journal-title":"Br J Nutr"},{"key":"2030_CR54","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1210\/jc.2007-1591","volume":"93","author":"B Galusca","year":"2008","unstructured":"Galusca B, Zouch M, Germain N, Bossu C, Frere D, Lang F, Lafage-Proust MH, Thomas T, Vico L, Estour B (2008) Constitutional thinness: unusual human phenotype of low bone quality. J Clin Endocrinol Metab 93:110\u2013117","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR55","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/jc.2007-2644","volume":"93","author":"T Chevalley","year":"2008","unstructured":"Chevalley T, Bonjour JP, Ferrari S, Rizzoli R (2008) Influence of age at menarche on forearm bone microstructure in healthy young women. J Clin Endocrinol Metab 93:2594\u20132601","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR56","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/8756-3282(94)90280-1","volume":"15","author":"S Khosla","year":"1994","unstructured":"Khosla S, Lufkin EG, Hodgson SF, Fitzpatrick LA, Melton LJ 3rd (1994) Epidemiology and clinical features of osteoporosis in young individuals. Bone 15:551\u2013555","journal-title":"Bone"},{"key":"2030_CR57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4158\/EP.6.4.296","volume":"6","author":"CA Moreira Kulak","year":"2000","unstructured":"Moreira Kulak CA, Schussheim DH, McMahon DJ, Kurland E, Silverberg SJ, Siris ES, Bilezikian JP, Shane E (2000) Osteoporosis and low bone mass in premenopausal and perimenopausal women. Endocr Pract 6:296\u2013304","journal-title":"Endocr Pract"},{"key":"2030_CR58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/sarh.2002.33725","volume":"32","author":"P Peris","year":"2002","unstructured":"Peris P, Guanabens N, Martinez de Osaba MJ, Monegal A, Alvarez L, Pons F, Ros I, Cerda D, Munoz-Gomez J (2002) Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum 32:64\u201370","journal-title":"Semin Arthritis Rheum"},{"key":"2030_CR59","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/ajg.2010.276","volume":"105","author":"DA Leffler","year":"2010","unstructured":"Leffler DA, Schuppan D (2010) Update on serologic testing in celiac disease. Am J Gastroenterol 105:2520\u20132524","journal-title":"Am J Gastroenterol"},{"key":"2030_CR60","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10067-005-1132-7","volume":"25","author":"PH Kann","year":"2006","unstructured":"Kann PH, Pfutzner A, Delling G, Schulz G, Meyer S (2006) Transiliac bone biopsy in osteoporosis: frequency, indications, consequences and complications. An evaluation of 99 consecutive cases over a period of 14\u00a0years. Clin Rheumatol 25:30\u201334","journal-title":"Clin Rheumatol"},{"key":"2030_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anai.2009.11.006","volume":"104","author":"SN Bains","year":"2010","unstructured":"Bains SN, Hsieh FH (2010) Current approaches to the diagnosis and treatment of systemic mastocytosis. Ann Allergy Asthma Immunol 104:1\u201310, quiz 10\u201312, 41","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2030_CR62","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/ard.2009.124511","volume":"69","author":"S Barete","year":"2010","unstructured":"Barete S, Assous N, de Gennes C et al (2010) Systemic mastocytosis and bone involvement in a cohort of 75 patients. Ann Rheum Dis 69:1838\u20131841","journal-title":"Ann Rheum Dis"},{"key":"2030_CR63","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruyere O et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391\u2013420","journal-title":"Osteoporos Int"},{"key":"2030_CR64","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1359\/jbmr.080703","volume":"24","author":"SJ Glover","year":"2009","unstructured":"Glover SJ, Gall M, Schoenborn-Kellenberger O, Wagener M, Garnero P, Boonen S, Cauley JA, Black DM, Delmas PD, Eastell R (2009) Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States. J Bone Miner Res 24:389\u2013397","journal-title":"J Bone Miner Res"},{"key":"2030_CR65","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1572-0241.2000.01850.x","volume":"95","author":"R Dresner-Pollak","year":"2000","unstructured":"Dresner-Pollak R, Karmeli F, Eliakim R, Ackerman Z, Rachmilewitz D (2000) Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. Am J Gastroenterol 95:699\u2013704","journal-title":"Am J Gastroenterol"},{"key":"2030_CR66","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bone.2009.05.012","volume":"45","author":"S Adami","year":"2009","unstructured":"Adami S, Bertoldo F, Braga V, Fracassi E, Gatti D, Gandolini G, Minisola S, Battista Rini G (2009) 25-Hydroxy vitamin D levels in healthy premenopausal women: association with bone turnover markers and bone mineral density. Bone 45:423\u2013426","journal-title":"Bone"},{"key":"2030_CR67","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00223-008-9126-5","volume":"82","author":"S Adami","year":"2008","unstructured":"Adami S, Bianchi G, Brandi ML, Giannini S, Ortolani S, DiMunno O, Frediani B, Rossini M (2008) Determinants of bone turnover markers in healthy premenopausal women. Calcif Tissue Int 82:341\u2013347","journal-title":"Calcif Tissue Int"},{"key":"2030_CR68","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00223-008-9184-8","volume":"83","author":"S Adami","year":"2008","unstructured":"Adami S, Gatti D, Viapiana O, Fiore CE, Nuti R, Luisetto G, Ponte M, Rossini M (2008) Physical activity and bone turnover markers: a cross-sectional and a longitudinal study. Calcif Tissue Int 83:388\u2013392","journal-title":"Calcif Tissue Int"},{"key":"2030_CR69","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bone.2009.10.011","volume":"46","author":"S Adami","year":"2010","unstructured":"Adami S, Zivelonghi A, Braga V, Fracassi E, Gatti D, Rossini M, Ulivieri FM, Viapiana O (2010) Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. Bone 46:244\u2013247","journal-title":"Bone"},{"key":"2030_CR70","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1210\/jc.2011-1387","volume":"96","author":"A Cohen","year":"2011","unstructured":"Cohen A, Dempster DW, Recker RR et al (2011) Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 96:3095\u20133105","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR71","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1515\/JPEM.2010.23.7.697","volume":"23","author":"AB Maggio","year":"2010","unstructured":"Maggio AB, Ferrari S, Kraenzlin M, Marchand LM, Schwitzgebel V, Beghetti M, Rizzoli R, Farpour-Lambert NJ (2010) Decreased bone turnover in children and adolescents with well controlled type 1 diabetes. J Pediatr Endocrinol Metab 23:697\u2013707","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2030_CR72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bone.2008.11.006","volume":"44","author":"P Garnero","year":"2009","unstructured":"Garnero P, Schott AM, Prockop D, Chevrel G (2009) Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations. Bone 44:461\u2013466","journal-title":"Bone"},{"key":"2030_CR73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11914-008-0007-7","volume":"6","author":"A Cohen","year":"2008","unstructured":"Cohen A, Shane E (2008) Treatment of premenopausal women with low bone mineral density. Curr Osteoporos Rep 6:39\u201346","journal-title":"Curr Osteoporos Rep"},{"key":"2030_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.a.31483","volume":"143","author":"A Superti-Furga","year":"2007","unstructured":"Superti-Furga A, Unger S (2007) Nosology and classification of genetic skeletal disorders: 2006 revision. Am J Med Genet A 143:1\u201318","journal-title":"Am J Med Genet A"},{"key":"2030_CR75","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jama.280.12.1067","volume":"280","author":"JS Finkelstein","year":"1998","unstructured":"Finkelstein JS, Klibanski A, Arnold AL, Toth TL, Hornstein MD, Neer RM (1998) Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1\u201334): a randomized controlled trial. JAMA 280:1067\u20131073","journal-title":"JAMA"},{"key":"2030_CR76","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1210\/jc.80.12.3689","volume":"80","author":"A Morishima","year":"1995","unstructured":"Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689\u20133698","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR77","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199410203311604","volume":"331","author":"EP Smith","year":"1994","unstructured":"Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056\u20131061","journal-title":"N Engl J Med"},{"key":"2030_CR78","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-2-40","volume":"2","author":"E Mornet","year":"2007","unstructured":"Mornet E (2007) Hypophosphatasia. Orphanet J Rare Dis 2:40","journal-title":"Orphanet J Rare Dis"},{"key":"2030_CR79","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","volume":"107","author":"Y Gong","year":"2001","unstructured":"Gong Y, Slee RB, Fukai N et al (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513\u2013523","journal-title":"Cell"},{"key":"2030_CR80","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000223694","volume":"16","author":"N Bishop","year":"2009","unstructured":"Bishop N (2009) Primary osteoporosis. Endocr Dev 16:157\u2013169","journal-title":"Endocr Dev"},{"key":"2030_CR81","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bone.2008.11.004","volume":"44","author":"A Ostertag","year":"2009","unstructured":"Ostertag A, Cohen-Solal M, Audran M, Legrand E, Marty C, Chappard D, de Vernejoul MC (2009) Vertebral fractures are associated with increased cortical porosity in iliac crest bone biopsy of men with idiopathic osteoporosis. Bone 44:413\u2013417","journal-title":"Bone"},{"key":"2030_CR82","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1359\/jbmr.2003.18.2.303","volume":"18","author":"I Pottelbergh Van","year":"2003","unstructured":"Van Pottelbergh I, Goemaere S, Zmierczak H, De Bacquer D, Kaufman JM (2003) Deficient acquisition of bone during maturation underlies idiopathic osteoporosis in men: evidence from a three-generation family study. J Bone Miner Res 18:303\u2013311","journal-title":"J Bone Miner Res"},{"key":"2030_CR83","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.bone.2005.06.017","volume":"37","author":"SL Ferrari","year":"2005","unstructured":"Ferrari SL, Deutsch S, Baudoin C, Cohen-Solal M, Ostertag A, Antonarakis SE, Rizzoli R, de Vernejoul MC (2005) LRP5 gene polymorphisms and idiopathic osteoporosis in men. Bone 37:770\u2013775","journal-title":"Bone"},{"key":"2030_CR84","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00198-004-1716-0","volume":"16","author":"MR Rubin","year":"2005","unstructured":"Rubin MR, Schussheim DH, Kulak CA, Kurland ES, Rosen CJ, Bilezikian JP, Shane E (2005) Idiopathic osteoporosis in premenopausal women. Osteoporos Int 16:526\u2013533","journal-title":"Osteoporos Int"},{"key":"2030_CR85","first-page":"582","volume":"26","author":"P Peris","year":"2008","unstructured":"Peris P, Martinez-Ferrer A, Monegal A, Martinez de Osaba MJ, Alvarez L, Ros I, Muxi A, Reyes R, Guanabens N (2008) Aetiology and clinical characteristics of male osteoporosis. Have they changed in the last few years? Clin Exp Rheumatol 26:582\u2013588","journal-title":"Clin Exp Rheumatol"},{"key":"2030_CR86","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10911-005-5394-0","volume":"10","author":"CS Kovacs","year":"2005","unstructured":"Kovacs CS (2005) Calcium and bone metabolism during pregnancy and lactation. J Mammary Gland Biol Neoplasia 10:105\u2013118","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2030_CR87","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nut.2003.10.011","volume":"20","author":"B Oliveri","year":"2004","unstructured":"Oliveri B, Parisi MS, Zeni S, Mautalen C (2004) Mineral and bone mass changes during pregnancy and lactation. Nutrition 20:235\u2013240","journal-title":"Nutrition"},{"key":"2030_CR88","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF02556384","volume":"48","author":"GN Kent","year":"1991","unstructured":"Kent GN, Price RI, Gutteridge DH, Rosman KJ, Smith M, Allen JR, Hickling CJ, Blakeman SL (1991) The efficiency of intestinal calcium absorption is increased in late pregnancy but not in established lactation. Calcif Tissue Int 48:293\u2013295","journal-title":"Calcif Tissue Int"},{"key":"2030_CR89","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1210\/jc.86.6.2344","volume":"86","author":"CS Kovacs","year":"2001","unstructured":"Kovacs CS (2001) Calcium and bone metabolism in pregnancy and lactation. J Clin Endocrinol Metab 86:2344\u20132348","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR90","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ecl.2005.09.004","volume":"35","author":"CS Kovacs","year":"2006","unstructured":"Kovacs CS, Fuleihan Gel H (2006) Calcium and bone disorders during pregnancy and lactation. Endocrinol Metab Clin N Am 35:21\u201351","journal-title":"Endocrinol Metab Clin N Am"},{"key":"2030_CR91","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1001\/jama.1993.03500240074029","volume":"269","author":"M Sowers","year":"1993","unstructured":"Sowers M, Corton G, Shapiro B, Jannausch ML, Crutchfield M, Smith ML, Randolph JF, Hollis B (1993) Changes in bone density with lactation. JAMA 269:3130\u20133135","journal-title":"JAMA"},{"key":"2030_CR92","first-page":"30","volume":"4","author":"ML Bianchi","year":"2009","unstructured":"Bianchi ML (2009) Osteoporosis during pregnancy. Eur Musculoskel Rev 4:30\u201334","journal-title":"Eur Musculoskel Rev"},{"key":"2030_CR93","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1097\/TA.0b013e31817daccf","volume":"68","author":"J Csotye","year":"2010","unstructured":"Csotye J, Sisak K, Bardocz L, Toth K (2010) Bilateral spontaneous displaced femoral neck fractures during pregnancy. J Trauma 68:E115\u2013E116","journal-title":"J Trauma"},{"key":"2030_CR94","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF01623007","volume":"6","author":"W Khovidhunkit","year":"1996","unstructured":"Khovidhunkit W, Epstein S (1996) Osteoporosis in pregnancy. Osteoporos Int 6:345\u2013354","journal-title":"Osteoporos Int"},{"key":"2030_CR95","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJM199708213370803","volume":"337","author":"HJ Kalkwarf","year":"1997","unstructured":"Kalkwarf HJ, Specker BL, Bianchi DC, Ranz J, Ho M (1997) The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med 337:523\u2013528","journal-title":"N Engl J Med"},{"key":"2030_CR96","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1155\/2007\/216162","volume":"21","author":"M Mauro","year":"2007","unstructured":"Mauro M, Radovic V, Armstrong D (2007) Improvement of lumbar bone mass after infliximab therapy in Crohn's disease patients. Can J Gastroenterol 21:637\u2013642","journal-title":"Can J Gastroenterol"},{"key":"2030_CR97","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1196\/annals.1346.055","volume":"1068","author":"M Pazianas","year":"2006","unstructured":"Pazianas M, Rhim AD, Weinberg AM, Su C, Lichtenstein GR (2006) The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn's disease. Ann N Y Acad Sci 1068:543\u2013556","journal-title":"Ann N Y Acad Sci"},{"key":"2030_CR98","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/ard.2008.106484","volume":"68","author":"G Haugeberg","year":"2009","unstructured":"Haugeberg G, Conaghan PG, Quinn M, Emery P (2009) Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study. Ann Rheum Dis 68:1898\u20131901","journal-title":"Ann Rheum Dis"},{"key":"2030_CR99","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S8756-3282(99)00171-4","volume":"25","author":"T Kemppainen","year":"1999","unstructured":"Kemppainen T, Kroger H, Janatuinen E et al (1999) Bone recovery after a gluten-free diet: a 5-year follow-up study. Bone 25:355\u2013360","journal-title":"Bone"},{"key":"2030_CR100","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1210\/jc.87.6.2883","volume":"87","author":"S Grinspoon","year":"2002","unstructured":"Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A (2002) Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 87:2883\u20132891","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR101","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/eat.20687","volume":"43","author":"LA Sim","year":"2010","unstructured":"Sim LA, McGovern L, Elamin MB, Swiglo BA, Erwin PJ, Montori VM (2010) Effect on bone health of estrogen preparations in premenopausal women with anorexia nervosa: a systematic review and meta-analyses. Int J Eat Disord 43:218\u2013225","journal-title":"Int J Eat Disord"},{"key":"2030_CR102","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/COH.0b013e3283478741","volume":"6","author":"J Hoy","year":"2011","unstructured":"Hoy J (2011) Bone, fracture and frailty. Curr Opin HIV AIDS 6:309\u2013314","journal-title":"Curr Opin HIV AIDS"},{"key":"2030_CR103","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1210\/jc.2003-031885","volume":"89","author":"KK Miller","year":"2004","unstructured":"Miller KK, Grieco KA, Mulder J, Grinspoon S, Mickley D, Yehezkel R, Herzog DB, Klibanski A (2004) Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab 89:3903\u20133906","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR104","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.1997.15.3.955","volume":"15","author":"PD Delmas","year":"1997","unstructured":"Delmas PD, Balena R, Confravreux E, Hardouin C, Hardy P, Bremond A (1997) Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study. J Clin Oncol 15:955\u2013962","journal-title":"J Clin Oncol"},{"key":"2030_CR105","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1210\/jc.2004-1444","volume":"90","author":"H Fuleihan Gel","year":"2005","unstructured":"Fuleihan Gel H, Salamoun M, Mourad YA, Chehal A, Salem Z, Mahfoud Z, Shamseddine A (2005) Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial. J Clin Endocrinol Metab 90:3209\u20133214","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR106","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1200\/JCO.1997.15.4.1341","volume":"15","author":"T Saarto","year":"1997","unstructured":"Saarto T, Blomqvist C, Valimaki M, Makela P, Sarna S, Elomaa I (1997) Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. J Clin Oncol 15:1341\u20131347","journal-title":"J Clin Oncol"},{"key":"2030_CR107","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1200\/JCO.2005.02.3515","volume":"24","author":"L Vehmanen","year":"2006","unstructured":"Vehmanen L, Elomaa I, Blomqvist C, Saarto T (2006) Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. J Clin Oncol 24:675\u2013680","journal-title":"J Clin Oncol"},{"key":"2030_CR108","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.bmt.1705196","volume":"37","author":"L Tauchmanova","year":"2006","unstructured":"Tauchmanova L, De Simone G, Musella T, Orio F, Ricci P, Nappi C, Lombardi G, Colao A, Rotoli B, Selleri C (2006) Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation. Bone Marrow Transplant 37:81\u201388","journal-title":"Bone Marrow Transplant"},{"key":"2030_CR109","unstructured":"Sagsveen M, Farmer JE, Prentice A, Breeze A (2003) Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density. Cochrane Database Syst Rev CD001297"},{"key":"2030_CR110","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2265.2008.03434.x","volume":"70","author":"I Chapman","year":"2009","unstructured":"Chapman I, Greville H, Ebeling PR, King SJ, Kotsimbos T, Nugent P, Player R, Topliss DJ, Warner J, Wilson JW (2009) Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF). Clin Endocrinol (Oxf) 70:838\u2013846","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2030_CR111","unstructured":"Conwell LS, Chang AB (2009) Bisphosphonates for osteoporosis in people with cystic fibrosis. Cochrane Database Syst Rev CD002010"},{"key":"2030_CR112","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1378\/chest.08-0608","volume":"134","author":"A Papaioannou","year":"2008","unstructured":"Papaioannou A, Kennedy CC, Freitag A et al (2008) Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial). Chest 134:794\u2013800","journal-title":"Chest"},{"key":"2030_CR113","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00223-006-0314-x","volume":"79","author":"CP Gilfillan","year":"2006","unstructured":"Gilfillan CP, Strauss BJ, Rodda CP, Bowden DK, Kean AM, Obaid M, Crawford BA (2006) A randomized, double-blind, placebo-controlled trial of intravenous zoledronic acid in the treatment of thalassemia-associated osteopenia. Calcif Tissue Int 79:138\u2013144","journal-title":"Calcif Tissue Int"},{"key":"2030_CR114","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3324\/haematol.12849","volume":"93","author":"E Voskaridou","year":"2008","unstructured":"Voskaridou E, Christoulas D, Konstantinidou M, Tsiftsakis E, Alexakos P, Terpos E (2008) Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial. Haematologica 93:1588\u20131590","journal-title":"Haematologica"},{"key":"2030_CR115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00198-009-0875-4","volume":"21","author":"M Mamtani","year":"2010","unstructured":"Mamtani M, Kulkarni H (2010) Bone recovery after zoledronate therapy in thalassemia-induced osteoporosis: a meta-analysis and systematic review. Osteoporos Int 21:183\u2013187","journal-title":"Osteoporos Int"},{"key":"2030_CR116","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.amjmed.2011.02.038","volume":"124","author":"M Laroche","year":"2011","unstructured":"Laroche M, Livideanu C, Paul C, Cantagrel A (2011) Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis. Am J Med 124:776\u2013778","journal-title":"Am J Med"},{"key":"2030_CR117","doi-asserted-by":"crossref","unstructured":"Bolland MJ, Grey A, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Gamble GD, Reid IR (2012) Effects of intravenous zoledronate on bone turnover and bone density persist for at least five years in HIV-infected men. J Clin Endocrinol Metab","DOI":"10.1210\/jc.2012-1424"},{"key":"2030_CR118","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/QAD.0b013e32831c8adc","volume":"23","author":"J Huang","year":"2009","unstructured":"Huang J, Meixner L, Fernandez S, McCutchan JA (2009) A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis. AIDS 23:51\u201357","journal-title":"AIDS"},{"key":"2030_CR119","doi-asserted-by":"crossref","unstructured":"Rozenberg S, Lanoy E, Bentata M et al (2012) Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120). AIDS Res Hum Retroviruses","DOI":"10.1089\/aid.2011.0224"},{"key":"2030_CR120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11914-996-0025-2","volume":"4","author":"F Rauch","year":"2006","unstructured":"Rauch F, Glorieux FH (2006) Treatment of children with osteogenesis imperfecta. Curr Osteoporos Rep 4:159\u2013164","journal-title":"Curr Osteoporos Rep"},{"key":"2030_CR121","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00223-010-9383-y","volume":"87","author":"JR Shapiro","year":"2010","unstructured":"Shapiro JR, Thompson CB, Wu Y, Nunes M, Gillen C (2010) Bone mineral density and fracture rate in response to intravenous and oral bisphosphonates in adult osteogenesis imperfecta. Calcif Tissue Int 87:120\u2013129","journal-title":"Calcif Tissue Int"},{"key":"2030_CR122","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00198-005-2032-z","volume":"17","author":"JP Devogelaer","year":"2006","unstructured":"Devogelaer JP, Goemaere S, Boonen S, Body JJ, Kaufman JM, Reginster JY, Rozenberg S, Boutsen Y (2006) Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int 17:8\u201319","journal-title":"Osteoporos Int"},{"key":"2030_CR123","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","volume":"62","author":"JM Grossman","year":"2010","unstructured":"Grossman JM, Gordon R, Ranganath VK et al (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 62:1515\u20131526","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2030_CR124","doi-asserted-by":"crossref","unstructured":"Lekamwasam S, Adachi JD, Agnusdei D, et al. (2012) A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int","DOI":"10.1007\/s00198-012-1958-1"},{"key":"2030_CR125","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.autrev.2010.03.002","volume":"9","author":"I Losada","year":"2010","unstructured":"Losada I, Sartori L, Di Gianantonio E, Zen M, Clementi M, Doria A (2010) Bisphosphonates in patients with autoimmune rheumatic diseases: can they be used in women of childbearing age? Autoimmun Rev 9:547\u2013552","journal-title":"Autoimmun Rev"},{"key":"2030_CR126","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00198-003-1399-y","volume":"14","author":"PN Biswas","year":"2003","unstructured":"Biswas PN, Wilton LV, Shakir SA (2003) Pharmacovigilance study of alendronate in England. Osteoporos Int 14:507\u2013514","journal-title":"Osteoporos Int"},{"key":"2030_CR127","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1210\/jc.2005-2548","volume":"91","author":"B Chan","year":"2006","unstructured":"Chan B, Zacharin M (2006) Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases. J Clin Endocrinol Metab 91:2017\u20132020","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR128","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S1701-2163(16)34026-9","volume":"30","author":"N Djokanovic","year":"2008","unstructured":"Djokanovic N, Klieger-Grossmann C, Koren G (2008) Does treatment with bisphosphonates endanger the human pregnancy? J Obstet Gynaecol Can 30:1146\u20131148","journal-title":"J Obstet Gynaecol Can"},{"key":"2030_CR129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0936-6555(05)80667-3","volume":"8","author":"TM Illidge","year":"1996","unstructured":"Illidge TM, Hussey M, Godden CW (1996) Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate. Clin Oncol (R Coll Radiol) 8:257\u2013258","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2030_CR130","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1359\/JBMR.040711","volume":"19","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Ward L, Glorieux FH (2004) Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases. J Bone Miner Res 19:1742\u20131745","journal-title":"J Bone Miner Res"},{"key":"2030_CR131","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00198-006-0112-3","volume":"17","author":"SM O'Sullivan","year":"2006","unstructured":"O'Sullivan SM, Grey AB, Singh R, Reid IR (2006) Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 17:1008\u20131012","journal-title":"Osteoporos Int"},{"key":"2030_CR132","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H","volume":"60","author":"N Patlas","year":"1999","unstructured":"Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A (1999) Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 60:68\u201373","journal-title":"Teratology"},{"key":"2030_CR133","first-page":"1338","volume":"35","author":"AF McKenzie","year":"1994","unstructured":"McKenzie AF, Budd RS, Yang C, Shapiro B, Hicks RJ (1994) Technetium-99\u00a0m-methylene diphosphonate uptake in the fetal skeleton at 30\u00a0weeks gestation. J Nucl Med 35:1338\u20131341","journal-title":"J Nucl Med"},{"key":"2030_CR134","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1210\/jc.2009-0996","volume":"94","author":"A Cohen","year":"2009","unstructured":"Cohen A, Liu XS, Stein EM, McMahon DJ, Rogers HF, Lemaster J, Recker RR, Lappe JM, Guo XE, Shane E (2009) Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 94:4351\u20134360","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl1","key":"2030_CR135","first-page":"S1072","volume":"24","author":"M Thayu","year":"2009","unstructured":"Thayu M, Shults J, Zemel B, Baldassano R, Lewis J, Leonard M (2009) Improvements in trabecular density, cortical dimensions, and a bone formation biomarker after initiation of infliximab therapy for childhood Crohn disease. J Bone Miner Res 24(Suppl1):S1072","journal-title":"J Bone Miner Res"},{"key":"2030_CR136","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2005.02.7102","volume":"25","author":"MF Gnant","year":"2007","unstructured":"Gnant MF, Mlineritsch B, Luschin-Ebengreuth G et al (2007) Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol 25:820\u2013828","journal-title":"J Clin Oncol"},{"key":"2030_CR137","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1210\/jc.2007-1434","volume":"93","author":"M Misra","year":"2008","unstructured":"Misra M, Prabhakaran R, Miller KK et al (2008) Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab 93:1231\u20131237","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR138","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/jc.2004-1659","volume":"90","author":"NH Golden","year":"2005","unstructured":"Golden NH, Iglesias EA, Jacobson MS, Carey D, Meyer W, Schebendach J, Hertz S, Shenker IR (2005) Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 90:3179\u20133185","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-012-2030-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2030-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T04:08:13Z","timestamp":1714018093000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-012-2030-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,9]]},"references-count":138,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2030"],"URL":"https:\/\/doi.org\/10.1007\/s00198-012-2030-x","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,9]]}}}